Annual Current Liabilities
$8.36 M
-$11.98 M-58.92%
June 30, 2024
Summary
- As of February 8, 2025, MEIP annual total current liabilities is $8.36 million, with the most recent change of -$11.98 million (-58.92%) on June 30, 2024.
- During the last 3 years, MEIP annual current liabilities has fallen by -$11.86 million (-58.66%).
- MEIP annual current liabilities is now -65.82% below its all-time high of $24.44 million, reached on June 30, 2022.
Performance
MEIP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.87 M
-$5.48 M-65.63%
September 30, 2024
Summary
- As of February 8, 2025, MEIP quarterly total current liabilities is $2.87 million, with the most recent change of -$5.48 million (-65.63%) on September 30, 2024.
- Over the past year, MEIP quarterly current liabilities has dropped by -$6.74 million (-70.13%).
- MEIP quarterly current liabilities is now -92.24% below its all-time high of $37.01 million, reached on December 31, 2020.
Performance
MEIP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MEIP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.9% | -70.1% |
| 3 y3 years | -58.7% | -70.1% |
| 5 y5 years | -41.6% | -70.1% |
MEIP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.8% | at low | -90.6% | at low |
| 5 y | 5-year | -65.8% | at low | -92.2% | at low |
| alltime | all time | -65.8% | +563.1% | -92.2% | +140.5% |
MEI Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.87 M(-65.6%) |
| Jun 2024 | $8.36 M(-58.9%) | $8.36 M(-13.1%) |
| Mar 2024 | - | $9.62 M(+19.6%) |
| Dec 2023 | - | $8.04 M(-6.1%) |
| Sep 2023 | - | $8.56 M(-57.9%) |
| Jun 2023 | $20.34 M(-16.8%) | $20.34 M(-13.9%) |
| Mar 2023 | - | $23.62 M(+4.3%) |
| Dec 2022 | - | $22.65 M(-3.3%) |
| Sep 2022 | - | $23.43 M(-4.1%) |
| Jun 2022 | $24.44 M(+20.9%) | $24.44 M(+2.0%) |
| Mar 2022 | - | $23.96 M(-21.5%) |
| Dec 2021 | - | $30.52 M(+0.5%) |
| Sep 2021 | - | $30.36 M(+50.2%) |
| Jun 2021 | $20.21 M(+46.9%) | $20.21 M(-39.4%) |
| Mar 2021 | - | $33.38 M(-9.8%) |
| Dec 2020 | - | $37.01 M(+17.6%) |
| Sep 2020 | - | $31.49 M(+128.9%) |
| Jun 2020 | $13.76 M(-3.8%) | $13.76 M(+34.1%) |
| Mar 2020 | - | $10.26 M(+3.3%) |
| Dec 2019 | - | $9.93 M(-1.4%) |
| Sep 2019 | - | $10.07 M(-29.6%) |
| Jun 2019 | $14.30 M(+81.4%) | $14.30 M(+20.7%) |
| Mar 2019 | - | $11.85 M(+8.7%) |
| Dec 2018 | - | $10.90 M(+127.9%) |
| Sep 2018 | - | $4.78 M(-39.3%) |
| Jun 2018 | $7.88 M(+62.0%) | $7.88 M(+75.8%) |
| Mar 2018 | - | $4.48 M(-13.9%) |
| Dec 2017 | - | $5.21 M(+16.7%) |
| Sep 2017 | - | $4.46 M(-8.2%) |
| Jun 2017 | $4.87 M(-11.7%) | $4.87 M(-2.5%) |
| Mar 2017 | - | $4.99 M(+50.3%) |
| Dec 2016 | - | $3.32 M(-80.7%) |
| Sep 2016 | - | $17.22 M(+212.4%) |
| Jun 2016 | $5.51 M(+11.2%) | $5.51 M(+36.9%) |
| Mar 2016 | - | $4.03 M(+19.2%) |
| Dec 2015 | - | $3.38 M(+8.0%) |
| Sep 2015 | - | $3.13 M(-36.9%) |
| Jun 2015 | $4.96 M(+7.4%) | $4.96 M(-25.3%) |
| Mar 2015 | - | $6.64 M(-3.5%) |
| Dec 2014 | - | $6.88 M(+29.7%) |
| Sep 2014 | - | $5.31 M(+15.0%) |
| Jun 2014 | $4.62 M | $4.62 M(+31.2%) |
| Mar 2014 | - | $3.52 M(+44.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $2.43 M(+65.7%) |
| Sep 2013 | - | $1.47 M(-12.5%) |
| Jun 2013 | $1.68 M(-5.6%) | $1.68 M(-6.0%) |
| Mar 2013 | - | $1.78 M(-0.8%) |
| Dec 2012 | - | $1.80 M(+10.2%) |
| Sep 2012 | - | $1.63 M(-8.1%) |
| Jun 2012 | $1.77 M(-25.3%) | $1.77 M(+18.3%) |
| Mar 2012 | - | $1.50 M(+15.7%) |
| Dec 2011 | - | $1.30 M(-18.4%) |
| Sep 2011 | - | $1.59 M(-33.1%) |
| Jun 2011 | $2.37 M(+35.3%) | $2.37 M(+27.3%) |
| Mar 2011 | - | $1.86 M(-17.6%) |
| Dec 2010 | - | $2.26 M(+20.6%) |
| Sep 2010 | - | $1.88 M(+6.9%) |
| Jun 2010 | $1.75 M(-57.6%) | $1.75 M(-23.4%) |
| Mar 2010 | - | $2.29 M(+54.1%) |
| Dec 2009 | - | $1.49 M(-40.1%) |
| Sep 2009 | - | $2.48 M(-40.1%) |
| Jun 2009 | $4.14 M(+20.3%) | $4.14 M(+55.3%) |
| Mar 2009 | - | $2.67 M(+5.2%) |
| Dec 2008 | - | $2.54 M(-11.2%) |
| Sep 2008 | - | $2.86 M(-17.0%) |
| Jun 2008 | $3.44 M(+37.0%) | $3.44 M(+5.5%) |
| Mar 2008 | - | $3.26 M(-3.1%) |
| Dec 2007 | - | $3.37 M(-2.3%) |
| Sep 2007 | - | $3.44 M(+37.0%) |
| Jun 2007 | $2.51 M(+99.4%) | $2.51 M(-0.8%) |
| Mar 2007 | - | $2.53 M(-6.7%) |
| Dec 2006 | - | $2.71 M(+127.3%) |
| Sep 2006 | - | $1.19 M(-5.2%) |
| Jun 2006 | $1.26 M(-55.7%) | $1.26 M(-65.3%) |
| Mar 2006 | - | $3.64 M(-25.0%) |
| Dec 2005 | - | $4.84 M(+25.4%) |
| Sep 2005 | - | $3.86 M(+35.9%) |
| Jun 2005 | $2.84 M(+49.1%) | $2.84 M(+49.3%) |
| Mar 2005 | - | $1.90 M(-31.7%) |
| Dec 2004 | - | $2.79 M(+31.3%) |
| Sep 2004 | - | $2.12 M(+11.4%) |
| Jun 2004 | $1.91 M(+40.9%) | $1.91 M(+34.6%) |
| Mar 2004 | - | $1.42 M(-78.8%) |
| Dec 2003 | - | $6.70 M(+287.3%) |
| Sep 2003 | - | $1.73 M(+27.8%) |
| Jun 2003 | $1.35 M | $1.35 M |
FAQ
- What is MEI Pharma annual total current liabilities?
- What is the all time high annual current liabilities for MEI Pharma?
- What is MEI Pharma annual current liabilities year-on-year change?
- What is MEI Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for MEI Pharma?
- What is MEI Pharma quarterly current liabilities year-on-year change?
What is MEI Pharma annual total current liabilities?
The current annual current liabilities of MEIP is $8.36 M
What is the all time high annual current liabilities for MEI Pharma?
MEI Pharma all-time high annual total current liabilities is $24.44 M
What is MEI Pharma annual current liabilities year-on-year change?
Over the past year, MEIP annual total current liabilities has changed by -$11.98 M (-58.92%)
What is MEI Pharma quarterly total current liabilities?
The current quarterly current liabilities of MEIP is $2.87 M
What is the all time high quarterly current liabilities for MEI Pharma?
MEI Pharma all-time high quarterly total current liabilities is $37.01 M
What is MEI Pharma quarterly current liabilities year-on-year change?
Over the past year, MEIP quarterly total current liabilities has changed by -$6.74 M (-70.13%)